Home » Drug R&D Firms Form Inter-Company CMC Alliance in Michigan
Drug R&D Firms Form Inter-Company CMC Alliance in Michigan
PharmaManufacturing.com
04/16/2009
Several Michigan companies have formed a strategic alliance centered around pharmaceutical chemistry, manufacturing and control development (CMC), aptly called the Michigan CMC Alliance. This alliance is comprised of contract service providers, each an expert in a distinct component in the drug-development spectrum, from preclinical to clinical phases and regulatory submission/approval.
Member organizations each have a firm foundation of experience and expertise within the pharmaceutical industry, along with a scientific infrastructure to deliver cost-effective, compliant results. The ability to leverage the intellectual capital resident within each organization is a distinct advantage to those in need of pharmaceutical CMC resources and expert strategies for comprehensive drug development.
The Michigan CMC Alliance brings together:
- Ash Stevens, Inc.: GMP AP development and manufacturing
- BioSTAT Consultants: Statistical services: design and analysis
- Eurofins AvTech Laboratories, Inc.: GMP and GLP analytical services
- Global Clinical Connections, LLC: Clinical supplies management
- Pharmaceutical Development Consulting, LLC: Formulation development and project management
- PharmaMed Resources, LLC: Quality assurance
- ProReg Resources, LLC: Regulatory consulting services
- Velesco Pharmaceutical Services: Formulation, analytical development and GMP manufacturing
"There is an abundance of pharma industry knowledge within Michigan; niche experts in each phase or component necessary to propel a drug forward through the development process. It seemed a natural fit to combine our forces in a strategic alliance," stated Bill Pfund, a director at Eurofins AvTech Laboratories. "Each company shares a common mission and vision along with a dedication to delivering quality, on-time results with the highest degree of scientific integrity."
Additional information on the Michigan CMC Alliance can be found at www.micmcalliance.com.
More News:
- 03/18/2010 Teva Beats Out Pfizer & Activa in 3.5BN Rationpharm Generics DealFrom CTV.ca
- 03/18/2010 Johnson & Johnson CEO Weldon Gets 11% 2009 Raise, to $25.6MFrom AP.com
- 03/17/2010 $75 Million Drug Heist is Bitter Pill for LillyFrom IndyStar.com
- 03/17/2010 R&D Investment by U.S. Biopharmaceutical Companies Remains Strong Despite Ongoing Economic Challenges
- 03/15/2010 Diabetes Drug From Lilly, Amylin Under ScrutinyFrom Forbes.com
- 03/12/2010 AstraZeneca Inks First Generic Drugs DealFrom Business.timesonline.co.uk
- 03/12/2010 AstraZeneca Job Cuts Reflect New Landscape For Drug InnovationFrom FT.com
- 03/10/2010 Novartis Goes Wireless for Process and Plant Info
- 03/10/2010 Concerns Raised about Tromethamine ContaminationFrom Rx-360
- 03/09/2010 Pittcon 2010: Thermo Fisher Scientific Continues in Growth Mode
- All news »
Get Connected Now!
- Featured White Papers

Print page